Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Apotex Technologies Inc
Apotex Technologies Inc_20100121

Apotex Technologies Inc patents


Recent patent applications related to Apotex Technologies Inc. Apotex Technologies Inc is listed as an Agent/Assignee. Note: Apotex Technologies Inc may have other listings under different names/spellings. We're not affiliated with Apotex Technologies Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Apotex Technologies Inc-related inventors


"fluorinated derivatives of 3-hydroxypyridin-4-ones"

Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron.... Apotex Technologies Inc

Fluorinated derivatives of 3-hydroxypyridin-4-ones

Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration... Apotex Technologies Inc

Extended release dosage form comprising cyclobenzaprine hydrochloride

An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided... Apotex Technologies Inc

Extended release dosage form comprising cyclobenzaprine hydrochloride

An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided... Apotex Technologies Inc

Extended release dosage form comprising cyclobenzaprine hydrochloride

An improved extended release capsule of cyclobenzaprine, and in particular, cyclobenzaprine hydrochloride, is provided. The improved capsule, comprising one or more matrix-type tablets providing extended release of the cyclobenzaprine, provides a dosage form that is bioequivalent to the currently marketed AMRIX® capsules while providing a simplified manufacturing process. Also provided... Apotex Technologies Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Apotex Technologies Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Apotex Technologies Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###